Clinical Diagnostics Automation - Global Business Strategic Report

Global Industry Analysts, Inc, May 2012, Pages: 545

This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Million by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

The report profiles 62 companies including many key and niche players such as Abaxis, Inc., Abbott Diagnostics, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Diagnostica Stago, HORIBA ABX S.A.S., Hudson Robotics, Inc., Ortho Clinical Diagnostics, Inc., QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., Sysmex America, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc., and Vital Scientific B.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying.

CLINICAL DIAGNOSTICS AUTOMATION

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Market Segmentation I-4
Automated Analyzers I-4
Stand-Alone Automation I-4
Total Laboratory Automation I-4

II. Executive Summary

1. INDUSTRY OVERVIEW II-1
Clinical Diagnostics Automation: A Global Insight II-1
The Road Ahead for Clinical Diagnostics Automation II-1
Growth Drivers in Lab Automation Market - A Snapshot II-2
Major Trends in Laboratory Automation Market II-2
Major Issues and Challenges in the Industry II-3
Automation - A Panacea to the Laboratories' Plight II-4
End-User and Technology-Led Aspects Drive Demand for Automation II-4
Automation - The Prime Solution to Enhance Laboratory Efficiency II-5
Total Laboratory Automation - Only Good Enough for Large
Hospitals II-5
Large Hospitals See Good Return on Investments by TLA II-5
Issues Continue to Plague Large Scale Automation Solutions II-6
Modular Automation Surges Ahead of TLA in Adoption II-6
Demand for POC Testing Rises II-7
POC Analyzers Looming Central Labs II-7
POC Testing - Drivers and Challenges II-7
Recession Halts Momentum in Lab Automation Market II-8
Regulatory Environment II-8

2. CLINICAL DIAGNOSTICS AUTOMATION - AN OVERVIEW II-9
Laboratory Automation: Order of the Day II-9
Benefits of Laboratory Automation II-9
Introduction to Clinical Diagnostics Automation II-9
Evolution of Clinical Diagnostics Automation II-10
Components of Laboratory Automation System II-10
Typical Diagnostic Laboratory Structure II-11
Laboratory Control and Information System II-11
Sample Storage II-11
Sample Preparation II-12
Transportation II-12
Analysis II-12
Clinical Diagnostics Automation by Market Segment II-12
Automated Analyzers II-12
Stand-Alone Automation II-12
Total Laboratory Automation (TLA) II-13
Limitations of TLA Systems II-13
Modular Automation: Emerging Alternative II-13
Total Laboratory Automation (TLA) Vs. Modular Laboratory
Automation II-14
Decentralized Testing Gains Importance II-14
Advantages of POC Testing Over Centralized Laboratory Testing II-14
Cost Analysis of POC Testing Vs. Laboratory Testing II-15
Cost Savings through Space Savings II-15
Major Components of Multi-Step Automation Process II-15
Consolidation of Workstation II-15
Information Management II-16

3. PRODUCT INTRODUCTIONS/INNOVATIONS II-17
Sysmex to Unveil Cell Image Analysis Portfolio II-17
BD Introduces Innova™ and InocuLAB Platforms II-17
HORIBA Medical Introduces Pentra C200 Compact Chemistry Analyzer II-18
Biocare Medical Introduces Automated Slide Stainer II-18
Roche Unveils Cobas 4800 System II-19
Siemens Introduces VersaCell™ and other Lab Automation Systems II-19
Sysmex America to Launch Sysmex TS-2000 Tube Sorter II-20
Randox Introduces Semi-Automated Analyzer II-20
QIAGEN Expands Diagnostic Instruments Portfolio II-20
Roche Receives CE Mark Certification for Cobas 8000 Modular
Analyzer II-20

4. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE
BUILDER II-22
IDH to Launch Products for Automated Diagnostic Analyzer II-22
Caliper Unveils Automated Ensemble and Reprise Systems II-22
bioMérieux to Launch Full Microbiology Laboratory Automation
Solutions II-22
Magellan and Subsidiaries to Roll Out Automated Systems and
Diagnostic Assays II-23
Transasia Bio-Medicals Unveils Automated Chemistry Analyzer II-23
Tecan Develops Cavro Omni Robot II-23
Abbott to Showcase ARCHITECT® ci4100TM Integrated System II-24
Horiba Unveils Two Laboratory Automation Systems II-24
Siemens Healthcare Diagnostics Launches MicroScan WalkAway
plus Systems II-24
Luminex to Introduce Innovative Bead-based Multiplexing Solution II-25

5. RECENT INDUSTRY ACTIVITY II-26
Danaher Acquires Beckman Coulter II-26
PerkinElmer Takes Over Caliper Life Sciences II-26
Roche Acquires PVT Probenverteiltechnik to Expand Clinical
Diagnostics Automation Portfolio II-26
Tecan Inks Global Manufacture and Supply Agreement with Enigma II-27
bioMérieux Inks Product Co-development and Marketing Agreement
with Philips II-27
NEXUS Snaps Up REMP from Tecan Group II-27
STRATEC Acquires US-based Ballista II-28
Sysmex America and Amerinet Ink Hematology Contract Agreement II-28
IRIS' Body Fluids Module Obtains FDA Clearance for Synovial
Fluid Analysis II-29
IRIS International Acquires Bench-Top Instrument Platform from
BioMicro Systems II-29
Sysmex Canada and EORLA Ink Capital Equipment and Vendor
Supply Service Agreements II-29
Thermo Fisher Scientific to Acquire B-R-A-H-M-S Holding II-30
Beckman Coulter Takes over Olympus' Diagnostic Business II-30
Tecan and Hologic Ink OEM Agreement II-31
BD Takes Over HandyLab II-31
Pievesestina-Located Clinical Lab Selects FlexLab Automation
System II-31
Hudson Control Group Adopts Original Name II-31
Abbott Obtains FDA Approval for PRISM HIV O Plus Test II-32
Ortho Clinical Establishes Remote Monitoring Center in France II-32
bioMerieux UK Bags Contract from The Royal Wolverhampton
Hospitals NHS Trust II-33
Bio-Reference and Sysmex America Enter Sole Source Agreement II-33

6. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-34
Sysmex America Receives Approval from US FDA II-34
Roche to Take Over Ventana Medical Systems II-34
Johnson & Johnson Nordic Takes Over Amic II-34
ELITech Group Acquires Vital Scientific II-34
Bio-Rad Inks Joint Marketing Agreement with Siemens Medical
Solutions II-35
Siemens Medical Solutions Diagnostics Extends Agreement with
Sysmex America II-35
RFCL Snaps Up Wipro BioMed II-35
Siemens Medical Solutions Acquired Dade Behring II-36

7. FOCUS ON SELECT GLOBAL PLAYERS II-37
Abaxis, Inc. (USA) II-37
Abbott Diagnostics (USA) II-37
Beckman Coulter, Inc. (USA) II-37
Becton, Dickinson and Company (USA) II-38
bioMérieux SA (France) II-38
Bio-Rad Laboratories, Inc. (USA) II-39
Caliper Life Sciences, Inc. (USA) II-39
Diagnostica Stago (France) II-39
HORIBA ABX S.A.S. (France) II-40
Hudson Robotics, Inc. (USA) II-40
Ortho Clinical Diagnostics, Inc. (USA) II-40
QIAGEN (USA) II-40
Roche Diagnostics (USA) II-41
Siemens Healthcare Diagnostics, Inc. (USA) II-41
Sysmex America, Inc. (USA) II-42
Tecan Group Ltd. (Switzerland) II-42
Thermo Fisher Scientific, Inc. (USA) II-42
Vital Scientific B.V. (The Netherlands) II-43

8. GLOBAL MARKET PERSPECTIVE II-44
Table 1: World Recent Past, Current and Future Analysis for
Clinical Diagnostics Automation by Geographic Region - US,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-44

Table 2: World Historic Review for Clinical Diagnostics
Automation by Geographic Region - US, Europe, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-45

Table 3: World 15-Year Perspective for Clinical Diagnostics
Automation by Geographic Region - Percentage Breakdown of
Dollar Sales for US, Europe, and Rest of World Markets for
Years 2003, 2011 and 2017 (includes corresponding Graph/Chart) II-46

Table 4: World Recent Past, Current and Future Analysis for
Automated Analyzers by Geographic Region - US, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-47

Table 5: World Historic Review for Automated Analyzers by
Geographic Region - US, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-48

Table 6: World 15-Year Perspective for Automated Analyzers by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe, and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-49

Table 7: World Recent Past, Current and Future Analysis for
Stand-alone Automation by Geographic Region - US, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-50

Table 8: World Historic Review for Stand-alone Automation by
Geographic Region - US, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-51

Table 9: World 15-Year Perspective for Stand-alone Automation
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Europe, and Rest of World Markets for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) II-52

Table 10: World Recent Past, Current and Future Analysis for
Total Lab Automation by Geographic Region - US, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-53

Table 11: World Historic Review for Total Lab Automation by
Geographic Region - US, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-54

Table 12: World 15-Year Perspective for Total Lab Automation
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Europe, and Rest of World Markets for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) II-55

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Automation Industry: At a Glance III-1
Major Drivers of Lab Automation Market III-1
Regulations Dictate Technological Changes in Laboratories III-1
Product Launches III-2
Strategic Corporate Developments III-6
Focus on Select Major Players III-11
B.Market Analytics III-16
Table 13: The US Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand- alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-16

Table 14: The US Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-17

Table 15: The US 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) III-18

2. EUROPE III-19
A.Market Analysis III-19
European Clinical Diagnostics Automation Market: A Prelude III-19
Economic Factors - Key Drivers to Growth III-20
Manufacturers Face Significant Challenges III-20
Future Trends III-20
Automation Supports Growth in West European IVD Market III-20
Product Launches III-21
Strategic Corporate Developments III-22
Focus on Select European Players III-26
B.Market Analytics III-28
Table 16: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-28

Table 17: European Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-29

Table 18: European 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-30

Table 19: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Geographic Region -
France, Germany, Italy, UK, Spain, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-31

Table 20: European Historic Review for Clinical Diagnostics
Automation by Geographic Region - France, Germany, Italy,
UK, Spain, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) III-32

Table 21: European 15-Year Perspective for Clinical
Diagnostics Automation by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, Italy, UK,
Spain, and Rest of Europe Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) III-33

2a. FRANCE III-34
A.Market Analysis III-34
Product Launches III-34
B.Market Analytics III-36
Table 22: French Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-36

Table 23: French Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-37

Table 24: French 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-38

2b. GERMANY III-39
A.Market Analysis III-39
Strategic Corporate Development III-39
B.Market Analytics III-40
Table 25: German Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-40

Table 26: German Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-41

Table 27: German 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-42

2c. ITALY III-43
Market Analytics III-43
Table 28: Italian Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-43

Table 29: Italian Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-44

Table 30: Italian 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-45

2d. THE UNITED KINGDOM III-46
Market Analytics III-46
Table 31: The UK Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-46

Table 32: The UK Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-47

Table 33: The UK 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-48

2e. SPAIN III-49
Market Analytics III-49
Table 34: Spanish Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-49

Table 35: Spanish Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-50

Table 36: Spanish 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-51

2f. FEST OF EUROPE III-52
Market Analytics III-52
Table 37: Rest of European Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Product
Segment - Automated Analyzers, Total Lab Automation, and
Stand-alone Automation Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-52

Table 38: Rest of European Historic Review for Clinical
Diagnostics Automation by Product Segment - Automated
Analyzers, Total Lab Automation, and Stand-alone Automation
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-53

Table 39: Rest of European 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-54

3. REST OF WORLD III-55
A.Market Analysis III-55
Focus on Select Regional Markets III-55
Asia-Pacific III-55
India III-55
Automation of Clinical Laboratories on the RiseIII-
55Challenges Abound in the Indian Clinical Diagnostics
Labs Market III-55
Diagnostics Arena Witnesses Rapid Transformation III-56
Private Enterprises Incite Changes in the Diagnostics Sector III-56
Singapore III-56
Current & Future Outlook III-56
Japan III-57
Automation - Past & Present III-57
Brazil III-57
Clinical Diagnostics Automation Market Poised to Grow III-57
Table 40: Brazilian Clinical Diagnostics Automation
Market (2011): Market Share Breakdown by Leading
Companies - Siemens Healthcare, Abbott Diagnostics, Roche
Diagnostics, and Others (includes corresponding
Graph/Chart) III-58
South Africa III-58
Laboratories Adopt Integrated Systems and Combined
Workstations III-58
Manufacturers' Shifting focus on Ease of Use and Enhanced
Automation Throughput III-58
Product Launches III-59
Strategic Corporate Development III-59
B.Market Analytics III-61
Table 41: Rest of World Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Product
Segment - Automated Analyzers, Total Lab Automation, and
Stand-alone Automation Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-61

Table 42: Rest of World Historic Review for Clinical
Diagnostics Automation by Product Segment - Automated
Analyzers, Total Lab Automation, and Stand-alone Automation
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-62

Table 43: Rest of World 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-63

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 62 (including Divisions/Subsidiaries - 68)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 40
Canada 3
Europe 22
France 3
Germany 4
The United Kingdom 6
Rest of Europe 9
Asia-Pacific (Excluding Japan) 3
------------------------------------------

Clinical diagnosis represents a time-consuming process, involving a wide array of processes, ranging from obtaining samples to the final reporting. Given the continued decline in government reimbursement rates for laboratory testing, cost-cutting measures adopted by the managed care industry, and the general shift towards cutting healthcare costs, clinical diagnostics laboratories are exploring ways to improve productivity with smaller budgets. Given this backdrop, several clinical diagnostics laboratories are increasingly adopting laboratory automation systems in order to tackle the problems associated with an increase in volume for diagnostic tests, decreasing reimbursement rates, and a diminished labor pool. The contribution of lab automation to the clinical diagnostics industry continues to expand, with the entry of more suppliers into the market with increased automation options. The technology enables simple and efficient workflow, resulting in an increased productivity, with minimum hands-on interaction. Besides, automation has become a major differentiating factor in a market characterized by intensified competition, and has emerged as an important means of survival for clinical laboratories.

The US represents the single largest market for clinical diagnostics automation worldwide, as stated by the new market research report on Clinical Diagnostics Automation. Europe represents the second largest market for clinical diagnostics automation. Driven primarily by the need to attain cost efficiencies, the European market for clinical diagnostics automation is witnessing growing investments in pre- and post-analytical clinical diagnostic processes. The market, however, faces few challenges, such as declining reimbursements for vendors, lack of standardized assays, and falling prices. Going forwards, the European market for laboratory automation systems is expected to be primarily driven by miniaturization. Miniaturization is likely to affect equipment's design, which in turn would lead to the development of sensitive and small analyzers, low volume liquid handlers, extra intelligent process control software, and high-definition plate formats. Market growth for clinical diagnostics automation, however, is expected to emanate mainly from the developing regions, driven primarily by the burgeoning population in Asia.

The global market for clinical diagnostics automation is led by automated clinical analyzers. Automation is expected to increasingly move towards handheld devices used in Point-Of-Care (POC) testing, given the rise in outpatient healthcare and homecare markets. Physicians opting for point-of-care testing are increasingly focusing on the use of small, handheld analyzers for tests, such as electrolytes, hematology, and glucose testing. Stand-alone automation represents the fastest growing segment in the global clinical diagnostics automation market, with a projected CAGR of 16.8% during the analysis period. Total Lab Automation (TLA) is considered to be the most comprehensive laboratory automation approach. It provides a higher level of integration and work consolidation in laboratories, and enables the testing of a wider variety of samples as compared to the stand-alone automation. However, TLA installation involves huge costs and consumes considerable time for small and medium sized laboratories, and is mostly ideal for use in large hospitals with 550 beds or more, or with a substantially large outpatient numbers. Adoption of TLA remains confined to only a few large hospitals, serving a niche market.

In the upcoming years, demand for automation solutions in clinical laboratories would gain from driving factors that emerge from the end-user life science industry as well as from the technological aspects of automation technology. While pharmaceutical companies continue to vie for increased efficiency and cost effectives, the biotech industry places substantial demand for new solutions in the backdrop of proteomics and genomics initiatives embarked by the sector. End-use sectors are expected to create substantial demand for automation solutions in a bid to realize enhanced data handling and higher throughput. Yet another major driver would be the increasing emphasis on ability to work with smaller material quantities. On the other side, advancements in aspects such as enhanced communication bandwidth, memory growth and processing power are expected to benefit technical aspects of automation solutions, in turn driving their demand. These improvisations are expected to deliver enhanced data collection, and their movement as well as sharing.

Global Industry Analysts ©

- Abaxis, Inc. (USA)
- Abbott Diagnostics (USA)
- Agilent Technologies, Inc. (USA)
- Axela, Inc. (Canada)
- Axis-Shield PLC (UK)
- Beckman Coulter, Inc. (USA)
- Becton, Dickinson and Company (USA)
- BD Diagnostics (USA)
- Biocare Medical LLC (USA)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (USA)
- Bio-Reference Laboratories, Inc. (USA)
- Biotest AG (Germany)
- B-R-A-H-M-S Holding GmbH (Germany)
- Caliper Life Sciences, Inc. (USA)
- Cardinal Health, Inc. (USA)
- Corgenix Medical Corporation (USA)
- Dako Denmark A/S (Denmark)
- Diagnostica Stago SAS (France)
- Dynex Technologies (USA)
- Enigma Diagnostics Ltd. (UK)
- Eppendorf AG (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Roche Diagnostics Corporation (USA)
- Genturadx (USA)
- Hamilton Storage Technologies, Inc. (USA)
- Helena Biosciences Europe (UK)
- Hologic, Inc. (USA)
- Horiba ABX SAS (France)
- Hudson Robotics, Inc. (USA)
- Immunodiagnostic Systems Holdings PLC (IDS) (UK)
- InnovaSystems, Inc. (USA)
- Inverness Medical Professional Diagnostics (USA)
- IRIS International, Inc. (USA)
- Johnson and Johnson Nordic AB (Sweden)
- Labotix Automation, Inc. (Canada)
- LabVantage Solutions, Inc. (USA)
- Leica Micosystems, Inc. (USA)
- Luminex Corporation (USA)
- Medica Corporation (USA)
- Merge Healthcare, Inc. (USA)
- Motoman Robotics (USA)
- Nexus Biosystems, Inc. (USA)
- Remp AG (Switzerland)
- Ortho-Clinical Diagnostics, Inc. (USA)
- PaR Systems, Inc. (USA)
- PerkinElmer, Inc. (USA)
- PerkinElmer Life and Analytical Sciences, Inc. (USA)
- Qiagen NV (The Netherlands)
- Qiagen, Inc. (USA)
- Randox Laboratories Ltd. (UK)
- RFCL Ltd. (India)
- Siemens Healthcare Diagnostics, Inc. (USA)
- Sotax AG (Switzerland)
- Stratec Biomedical Systems AG (Germany)
- Sysmex America, Inc. (USA)
- TAP Biosystems (UK)
- Tecan Group Ltd. (Switzerland)
- Thermo Fisher Scientific, Inc. (USA)
- Dionex Corporation (USA)
- Transasia Bio-Medicals Ltd. (India)
- TREK Diagnostic Systems, Inc. (USA)
- Ventana Medical Systems, Inc. (USA)
- Viracor-IBT Laboratories, Inc. (USA)
- Vital Scientific BV (The Netherlands)
- Xceed Molecular Corporation (Canada)
- Xiril AG (Switzerland)
- ZyGEM Corporation Ltd. (New Zealand)

Customers who bought this item also bought

• Medical Nutrition - A Global Market Overview
• Diabetes Diagnostics - Global Strategic Business Report
• Molecular Diagnostics - Global Strategic Business Report
• Disinfectants - Global Strategic Business Report
• Syringes (Disposable and Reusable) - Global Strategic Business Report
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• Dental Supplies - Global Strategic Business Report
• Anesthesia Disposables - Global Strategic Business Report
• Ostomy and Incontinence Products - Global Strategic Business Report
• Home Health Care Services - Global Outlook